脂毒性
脂质代谢
炎症
脂滴
脂质信号
脂肪生成
医学
二酰甘油激酶
糖尿病
化学
内科学
内分泌学
药理学
胰岛素抵抗
生物化学
信号转导
蛋白激酶C
作者
Wei Yu,Haoyu Yang,Zhou Ling,Hang Xing,Pengfei Xie,Wang Anzhu,Lili Zhang,Linhua Zhao
标识
DOI:10.3389/fimmu.2025.1549484
摘要
Diabetic kidney disease (DKD) is one of the major complications of diabetes, and its pathological progression is closely associated with lipid metabolic reprogramming. Under diabetic conditions, renal cells undergo significant lipid metabolic abnormalities, including increased lipid uptake, impaired fatty acid oxidation, disrupted cholesterol efflux, and enhanced lipid catabolism, as adaptive responses to metabolic stress. These changes result in the accumulation of lipids such as free fatty acids, diacylglycerol, and ceramides, leading to lipotoxicity that triggers inflammation and fibrosis. Hypoxia in the DKD microenvironment suppresses fatty acid oxidation and promotes lipid synthesis through the HIF-1α pathway, while chronic inflammation exacerbates lipid metabolic disturbances via inflammatory cytokines, inflammasomes, and macrophage polarization. Targeting lipid metabolism represents a promising therapeutic strategy for alleviating DKD; however, further clinical translational studies are warranted to validate the efficacy and safety of these approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI